Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Down syndrome

S Takashima1

  • 1Department of Mental Retardation and Birth Defect Research, National Institute of Neuroscience, Tokyo, Japan.

Current Opinion in Neurology
|April 1, 1997
PubMed
Summary
This summary is machine-generated.

Down syndrome, a genetic condition caused by trisomy 21, is linked to early-onset dementia. Research focuses on improved detection methods and understanding the role of amyloid precursor protein in cognitive decline.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Downward shift of coronary pressure-flow relationship following a brief period of ischemia in dogs.

The American journal of physiology·1995
Same author

Hashimoto thyroiditis: correlation of MR imaging signal intensity with histopathologic findings and thyroid function test results.

Radiology·1995
Same author

Lissencephaly gene product. Localization in the central nervous system and loss of immunoreactivity in Miller-Dieker syndrome.

The American journal of pathology·1995
Same author

[Neuropathological findings in a case of Hutchinson-Gilford progeria syndrome].

No to hattatsu = Brain and development·1995
Same author

Isolation and characterization of heparin-binding growth factors in human leiomyomas and normal myometrium.

Biology of reproduction·1995
Same author

Developmental changes of apolipoprotein E immunoreactivity in Down syndrome brains.

Brain research. Developmental brain research·1995
Same journal

Movement disorders and Parkinson's disease: collaborative and interdisciplinary research to advance understanding of neural circuit dysfunction, pathophysiology, and care: new horizons in technology, neuroimaging, neurophysiology, and genetics toward personalized medicine.

Current opinion in neurology·2026
Same journal

Editorial introduction.

Current opinion in neurology·2026
Same journal

Multimodal mapping of balance dysfunction in Parkinson's disease: a consensus roadmap for research and intervention.

Current opinion in neurology·2026
Same journal

Tourette syndrome: brain neurophysiology, circuit dysfunction, and neuromodulation across invasive and noninvasive approaches.

Current opinion in neurology·2026
Same journal

Dystonia: from phenotypes to genetics and therapeutic advances.

Current opinion in neurology·2026
Same journal

What can we learn from eye movements in movement disorders and Parkinson's disease?

Current opinion in neurology·2026
See all related articles

Area of Science:

  • Genetics
  • Neurology
  • Medical Diagnostics

Background:

  • Down syndrome (trisomy 21) is a genetic disorder associated with intellectual disability and early-onset Alzheimer-like dementia.
  • The exact pathogenesis of cognitive decline in Down syndrome is not fully understood.
  • Early detection and understanding of dementia in Down syndrome are crucial for patient care.

Purpose of the Study:

  • To review current advancements in the detection of Down syndrome.
  • To explore the underlying mechanisms of precocious dementia in adults with Down syndrome.
  • To highlight the potential of animal models in Down syndrome research.

Main Methods:

  • Review of established and emerging diagnostic tools for Down syndrome.
  • Analysis of molecular factors contributing to dementia in Down syndrome.

Related Experiment Videos

  • Discussion of the utility of animal models, including transgenic mice, in studying Down syndrome pathogenesis.

    • Main Results:

    • Improved detection methods for Down syndrome include maternal serum markers (human chorionic gonadotrophin, unconjugated estriol, amyloid precursor protein), ultrasound (nuchal skinfold), and genetic probes.
    • Overproduction of amyloid-beta 42 due to gene duplication is implicated in early-onset dementia in Down syndrome.
    • Animal models offer promising avenues for elucidating the genetic and pathogenic basis of intellectual disability and dementia.

    Conclusions:

    • Advances in diagnostics are enhancing the detection rates of Down syndrome.
    • Amyloid precursor protein overproduction is a key factor in the development of dementia in Down syndrome.
    • Further research using animal models is essential for a comprehensive understanding of Down syndrome-related cognitive impairments.